Kelly L. Stratton, MD, is an assistant professor of Urologic Oncology in the OU Department of Urology. Prior to joining the OU Urology team in 2014, he completed his fellowship training in the Department of Surgery (Urology Service) at Memorial Sloan-Kettering Cancer Center in New York, and his residency at Vanderbilt University Medical Center Department of Urology. He completed his MD with special distinction here at the OU College of Medicine in 2007.
Dr. Stratton brings experience with state-of-the art imaging for the diagnosis and treatment of prostate cancer. He is interested in the application of new technology capable of blending MRI images with real-time ultrasound to improve prostate biopsy and cancer detection. Using these techniques he can assist patients considering prostate cancer treatment options including those who are candidates for active surveillance. He also utilizes genomic testing to help provide personalized treatment plans for patients diagnosed with urologic cancer. Dr. Stratton is involved in several clinical trials that provide the most advanced treatment options currently available.
Dr. Stratton holds memberships in the American Society of Clinical Oncology, the Society of Urologic Oncology and the American Urological Association. He serves as a reviewer for the Journal of Urology and was recently awarded the Best Reviewer in Oncology. He is a contributor to the Practical Reviews in Urology with an emphasis on urologic oncology. Dr. Stratton is also an author of numerous publications and abstracts, as well as of a book chapter for the American Cancer Society regarding inherited predisposition to cancer.
Urologic Oncology Fellowship: Chief Administrative Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
Urologic Residency/Internship: Vanderbilt University Medical Center, Nashville, TN
Medical School: College of Medicine, University of Oklahoma Health Science Center
- Prostate Cancer including advanced imaging with prostate MRI, active surveillance, and nerve sparing robotic prostatectomy
- MRI/Ultrasound fusion prostate biopsy using UroNav System
- Castration-resistant prostate cancer
- Bladder Cancer including bladder preservation and radical cystectomy
- Kidney Cancer including cytoreductive nephrectomy, IVC thrombectomy, and robotic-assisted partial nephrectomy
Testicular Cancer including surveillance, nerve-sparing RPLND, and post-chemotherapy RPLND
Penile Cancer including inguinal lymphadenectomy
American Urologic Association
Society of Urologic Oncology
American Society of Clinical Oncology
South Central Section of the AUA
Vanderbilt Urology Society
Alpha Omega Alpha Medical Honor Society